| Neuropsychiatry, gynaecology, ophthalmology, vaccines and the treatment of inflammations are the main therapeutic areas of interest for Angelini Farmacêutica in the ethical pharmaceuticals sector. The recent introduction of two new specialty fields, oncology and antibiotic therapy, demonstrates Angelini’s strength and its constant striving towards innovation and specialization. The package inserts are only intended to provide information for a correct use of drugs and to promote a responsible and sound culture of health. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Neuropsychiatry In this field, Angelini boasts the well-established international experience gained with trazodone, a truly unique molecule which was discovered in the Angelini research laboratories in the Seventies and was subsequently registered in many European and non-European countries. Trazodone is indicated for the treatment of depressive disorders with or without anxiety. Angelini is also engaged in the marketing of drugs indicated for the treatment of cognitive impairment, which are useful for the improvement of circulation and vascular processes occurring in the brain.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 top | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gynaecology The Angelini gynaecological drugs are specifically intended for the treatment of vulvovaginal infections and inflammations in order to solve the intimate and delicate problems a woman may encounter throughout her life. In particular, benzydamine is a nonsteroidal anti-inflammatory drug which was developed by the Angelini research laboratories and is now marketed in Italy, Spain and Portugal.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| top | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ophthalmology IIn this field, Angelini offers a wide range of quality products including anti-inflammatory drugs, pharmaceuticals for the treatment of cataracts and glaucoma, ocular lubricants and antiallergic drugs. In particular, the active substance bendazac lysine, an original molecule for the treatment of cataracts which was developed by the Angelini research laboratories, has been registered and successfully marketed in many countries worldwide.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| top | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anti-Inflammatory Pharmaceuticals The portfolio of anti-inflammatory pharmaceuticals developed by Angelini includes drugs containing nimesulide, diclofenac, benzydamine and paracetamol. These drugs provide both practitioners and patients with a wide choice of remedies for the treatment of rheumatic, muscle/joint and oropharyngeal pain as well as other occasional pain including headache and dysmenorrhoea.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| top | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vaccines Angelini Farmacêutica is active not only in the treatment of pathological diseases but also in their prevention, offering a comprehensive approach to human health. Its portfolio of ethical pharmaceuticals also includes two important vaccines: the first vaccine for protection against the influenza virus and the second vaccine against hepatitis A.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| top | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Pharmaceuticals IIn addition, Angelini Farmacêutica has developed and is engaged in the marketing of pharmaceuticals for cardiovascular and respiratory disorders (especially affecting children) as well as antibiotics and gastrointestinal drugs.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| top |
Go to angelini site